CKD-MBD is defined in terms of the presence of one or more of the following: biochemical abnormalities (abnormal serum calcium, phosphorus, parathyroid hormone [PTH], and fibroblast growth factor 23 levels), bone abnormalities, and vascular calcification 1. This evidence concerns the gene PTH and chronic kidney disease.